Bisulepine

Drug profile

Key facts

Bisulepine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including HRH1.

• Molecular targets: HRH1 (1 listed in DrugCentral).
• Molecular formula: C17H19NS2; molecular weight 301.48 g/mol.

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Histamine H1 receptor	HRH1	antagonist	—

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Cytokine release syndrome	100.1
Haemolytic uraemic syndrome	52.2
COVID-19 pneumonia	46.3
Oligohydramnios	42.8

Chemical structure

• Molecular formula: C₁₇H₁₉NS₂
• Molecular weight: 301.48 g/mol
• CAS number: —
• InChIKey: ZLJLUTCIUOCIQM-NVNXTCNLSA-N
• PubChem CID: 6436111

CN(C)CC\C=C1/C2=C(SC=C2)SCC2=C1C=CC=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Bisulepine work?

Its molecular targets in DrugCentral include HRH1 (antagonist).

What is the chemical formula of Bisulepine?

Bisulepine has the molecular formula C17H19NS2 and a molecular weight of 301.48 g/mol.

Sources

• DrugCentral drug card 383 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• PubChem CID 6436111 — chemical identifiers
• FDA UNII 595726R32U — substance identity
• UniProt P35367 (HRH1) — target protein
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.